Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dienogest, LNG-IUS, and Sanjie Zhentong Capsule for painful adenomyosis
ChiCTR2000029010Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dienogest, avatrombopag and San Jie Zhen Tong in adenomyosis (4 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoints: Dysmenorrhea degree at 12 months, Menstrual volume at 12 months and 2 more. Started Dec 2019; status: recruiting.
02
Drugs
dienogestavatrombopagSan Jie Zhen Tong
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2000029010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029010.